In Vitro Anti-Helicobacter pylori Activities of New Rifamycin Derivatives, KRM-1648 and KRM-1657

The new rifamycin derivatives KRM-1657 and KRM-1648 were evaluated for their in vitro antimicrobial activities against 44 strains of Helicobacter pylori. Although the drugs were not very active against other gram-negative bacteria, the MICs at which 90% of isolates are inhibited for these drugs were...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Akada, Junko K., Shirai, Mutsunori, Fujii, Kenji, Okita, Kiwamu, Nakazawa, Teruko
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89113/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10223916/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.5.1072
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!